From hyperglycemia to intervertebral disc damage: exploring diabetic-induced disc degeneration
Open accessThe DOI matches its Crossref record; 125 of the 125 references it cites were found in a registry or an index.
Abstract
The incidence of lumbar disc herniation has gradually increased in recent years, and most patients have symptoms of low back pain and nerve compression, which brings a heavy burden to patients and society alike. Although the causes of disc herniation are complex, intervertebral disc degeneration (IDD) is considered to be the most common factor. The intervertebral disc (IVD) is composed of the upper and lower cartilage endplates, nucleus pulposus, and annulus fibrosus. Aging, abnormal mechanical stress load, and metabolic disorders can exacerbate the progression of IDD. Among them, high glucose and high-fat diets (HFD) can lead to fat accumulation, abnormal glucose metabolism, and inflammation, which are considered important factors affecting the homeostasis of IDD. Diabetes and advanced glycation end products (AGEs) accumulation- can lead to various adverse effects on the IVD, including cell senescence, apoptosis, pyroptosis, proliferation, and Extracellular matrix (ECM) degradation. While current research provides a fundamental basis for the treatment of high glucose-induced IDD patients. further exploration into the mechanisms of abnormal glucose metabolism affecting IDD and in the development of targeted drugs will provide the foundation for the effective treatment of these patients. We aimed to systematically review studies regarding the effects of hyperglycemia on the progress of IDD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The GLP-1R signaling pathway may also affect the expression of MMP-13 and ADAMTS5, by reducing the signal transduction caused by IL-1β, thus decreasing their synthesis.345,346”
From Glucagon-like peptide-1 receptor: mechanisms and advances in therapy (2024) · cites this paper as [346]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
4 retracted
Wang, W., Li, P., Xu, J., Wu, X., Guo, Z., Fan, L., Song, R., Wang, J., Wei, L., & Teng, H. (2018) · Bioscience Reports · doi:10.1042/bsr20171454 · Cited by 75
RetractedShan, L., Yang, D., Zhu, D., Feng, F., & Li, X. (2019) · Bioscience Reports · doi:10.1042/bsr20190853 · Cited by 30 · cited 1×
“In mechanism, inhibition of JNK pathway and p38 MAPK signal pathways may attenuate the effect of high glucose on apoptosis of the AF cells (105).”
BackgroundRetractedPang, L., Yang, K., & Zhang, Z. (2020) · Bioscience Reports · doi:10.1042/bsr20200262 · Cited by 14 · cited 1×
“After high glucose induction, the protein expression of ER stress markers CHOP, ATF-6, and ATF-6 signi fi cantly increased and induced apoptosis in the AF cells (106).”
BackgroundRetractedLiu, Z., Zhang, Z., Zhang, A., Zhang, F., Du, W., Zhang, Y., Zhang, R., Xu, J., Wu, X., Zhang, C., et al. (2019) · Bioscience Reports · doi:10.1042/bsr20190170 · Cited by 11 · cited 1×
“On the other hand, the addition of osteogenic protein-1 (OP-1) reverses NP matrix catabolism induced by high glucose (95).”
BackgroundRetractedShedding light on the cell biology of extracellular vesicles
van Niel, G., D'Angelo, G., & Raposo, G. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.125 · Cited by 8,369
Atkinson, M. A., Eisenbarth, G. S., & Michels, A. W. (2014) · The Lancet · doi:10.1016/s0140-6736(13)60591-7 · Cited by 2,931 · cited 11×
“These studies show that T1D is an important factor in promoting the progress of IDD, and that effective blood glucose control is the key strategy to delay IDD.”
BackgroundInfluentialGlucagon-like peptide 1 (GLP-1)
Müller, T. D., Finan, B., Bloom, S. R., D'Alessio, D., Drucker, D. J., Flatt, P. R., Fritsche, A., Gribble, F., Grill, H. J., Habener, J. F., et al. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.09.010 · Cited by 1,868 · cited 1×
“Glucagon-like peptide-1 (GLP-1) is a key intestinal insulin-stimulating hormone that regulates glucose and energy homeostasis (108, 109).”
BackgroundRole of cytokines in intervertebral disc degeneration: pain and disc content
Risbud, M. V., & Shapiro, I. M. (2014) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2013.160 · Cited by 1,767
Experimental and Therapeutic Medicine
(2026) · Experimental and Therapeutic Medicine · doi:10.3892/etm · Cited by 1,728
Knezevic, N. N., Candido, K. D., Vlaeyen, J. W. S., Van Zundert, J., & Cohen, S. P. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00733-9 · Cited by 1,345
The Discovery and Development of Liraglutide and Semaglutide
Knudsen, L. B., & Lau, J. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00155 · Cited by 970 · cited 3×
“LIR is considered to be a powerful therapeutic choice for T2D by binding to GLP-1R to regulate insulin and cell proliferation, differentiation and apoptosis (111, 112).”
BackgroundMechanics and biology in intervertebral disc degeneration: a vicious circle
Vergroesen, P.-P. A., Kingma, I., Emanuel, K. S., Hoogendoorn, R. J. W., Welting, T. J., van Royen, B. J., van Dieën, J. H., & Smit, T. H. (2015) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2015.03.028 · Cited by 918 · cited 1×
“Biomolecule therapy aims to target disease states characterized by decreased anabolism and increased catabolism (37 – 39).”
Background(2026) · Molecular Medicine Reports · doi:10.3892/mmr · Cited by 913
Advanced Glycation End Products and Diabetes Mellitus: Mechanisms and Perspectives
Khalid, M., Petroianu, G., & Adem, A. (2022) · Biomolecules · doi:10.3390/biom12040542 · Cited by 879 · cited 1×
“The continuous increase of blood glucose levels in patients with diabetes can lead to non-enzymatic macromolecular glycosylation and eventually to the formation of advanced glycation end products (AGEs) (67, 68).”
BackgroundExosomes as mediators of intercellular crosstalk in metabolism
Isaac, R., Reis, F. C. G., Ying, W., & Olefsky, J. M. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.08.006 · Cited by 820
Bhatti, J. S., Sehrawat, A., Mishra, J., Sidhu, I. S., Navik, U., Khullar, N., Kumar, S., Bhatti, G. K., & Reddy, P. H. (2022) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2022.03.019 · Cited by 693
The role of IL-1β and TNF-α in intervertebral disc degeneration
Wang, Y., Che, M., Xin, J., Zheng, Z., Li, J., & Zhang, S. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110660 · Cited by 627
Exercise therapy for chronic low back pain
Hayden, J. A., Ellis, J., Ogilvie, R., Malmivaara, A., & van Tulder, M. W. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009790.pub2 · Cited by 589
Emerging Targets in Type 2 Diabetes and Diabetic Complications
Demir, S., Nawroth, P. P., Herzig, S., & Ekim Üstünel, B. (2021) · Advanced Science · doi:10.1002/advs.202100275 · Cited by 525 · cited 1×
“Type II diabetes (T2D) is a chronic metabolic disease characterized by long-term hyperglycemia and insulin resistance (IR), and the decrease of insulin absorption and glucose utilization leads to more compensatory insulin secretion, resulting in hyperinsulinemia (57, 58).”
BackgroundAging and age related stresses: a senescence mechanism of intervertebral disc degeneration
Wang, F., Cai, F., Shi, R., Wang, X.-H., & Wu, X.-T. (2016) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2015.09.019 · Cited by 522
Vlaeyen, J. W. S., Maher, C. G., Wiech, K., Van Zundert, J., Meloto, C. B., Diatchenko, L., Battié, M. C., Goossens, M., Koes, B., & Linton, S. J. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0052-1 · Cited by 497
Moldogazieva, N. T., Mokhosoev, I. M., Mel’nikova, T. I., Porozov, Y. B., & Terentiev, A. A. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/3085756 · Cited by 493
A new immunometabolic perspective of intervertebral disc degeneration
Francisco, V., Pino, J., González-Gay, M. Á., Lago, F., Karppinen, J., Tervonen, O., Mobasheri, A., & Gualillo, O. (2022) · Nature Reviews Rheumatology · doi:10.1038/s41584-021-00713-z · Cited by 462
Clinical application of mesenchymal stem cell in regenerative medicine: a narrative review
Margiana, R., Markov, A., Zekiy, A. O., Hamza, M. U., Al-Dabbagh, K. A., Al-Zubaidi, S. H., Hameed, N. M., Ahmad, I., Sivaraman, R., Kzar, H. H., et al. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-03054-0 · Cited by 429
Mohd Isa, I. L., Teoh, S. L., Mohd Nor, N. H., & Mokhtar, S. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010208 · Cited by 365 · cited 1×
“Furthermore, the IVD can increase the range of spinal movement, withstand pressure, cushion vibration and protect the spinal cord (17).”
BackgroundDooley, K., McConnell, R. E., Xu, K., Lewis, N. D., Haupt, S., Youniss, M. R., Martin, S., Sia, C. L., McCoy, C., Moniz, R. J., et al. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.01.020 · Cited by 307
RNA packaging into extracellular vesicles: An orchestra of RNA‐binding proteins?
Fabbiano, F., Corsi, J., Gurrieri, E., Trevisan, C., Notarangelo, M., & D'Agostino, V. G. (2020) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12043 · Cited by 302
Autophagy and the hallmarks of aging
Kaushik, S., Tasset, I., Arias, E., Pampliega, O., Wong, E., Martinez-Vicente, M., & Cuervo, A. M. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101468 · Cited by 285 · cited 1×
“Autophagy has been shown to prevent premature aging under various conditions, and autophagy defects may lead to aging (101, 102).”
BackgroundWu, P. H., Kim, H. S., & Jang, I.-T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21062135 · Cited by 266 · cited 1×
“On the drug therapy aspect, opioids, steroids, and non-steroidal anti-in fl ammatory drugs play an important role in controlling pain and improving function and quality of life (28 – 30).”
BackgroundKamali, A., Ziadlou, R., Lang, G., Pfannkuche, J., Cui, S., Li, Z., Richards, R. G., Alini, M., & Grad, S. (2021) · Theranostics · doi:10.7150/thno.48987 · Cited by 263 · cited 1×
“Approximately 60-80% of patients experience chronic low back pain throughout their lifetime (3 – 5).”
BackgroundNF‐κB signalling pathways in nucleus pulposus cell function and intervertebral disc degeneration
Zhang, G., Liu, M., Chen, H., Wu, Z., Gao, Y., Ma, Z., He, X., & Kang, X. (2021) · Cell Proliferation · doi:10.1111/cpr.13057 · Cited by 261
An Update on Adipose‐Derived Stem Cells for Regenerative Medicine: Where Challenge Meets Opportunity
Qin, Y., Ge, G., Yang, P., Wang, L., Qiao, Y., Pan, G., Yang, H., Bai, J., Cui, W., & Geng, D. (2023) · Advanced Science · doi:10.1002/advs.202207334 · Cited by 260 · cited 1×
“In recent years, stem cell therapy has been widely used in cell-based regenerative medicine (97 – 99).”
BackgroundGlucagon‐like peptide‐1 receptor agonists in type 2 diabetes treatment: are they all the same?
Gentilella, R., Pechtner, V., Corcos, A., & Consoli, A. (2019) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3070 · Cited by 227 · cited 1×
“LIR is considered to be a powerful therapeutic choice for T2D by binding to GLP-1R to regulate insulin and cell proliferation, differentiation and apoptosis (111, 112).”
BackgroundBiomarkers for type 2 diabetes
Laakso, M. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.06.016 · Cited by 225 · cited 1×
“Type II diabetes (T2D) is a chronic metabolic disease characterized by long-term hyperglycemia and insulin resistance (IR), and the decrease of insulin absorption and glucose utilization leads to more compensatory insulin secretion, resulting in hyperinsulinemia (57, 58).”
Background(2016) · doi:10.22203/ecm · Cited by 214 · cited 2×
“The nutrition of the NP is mainly supplied by the vertebral body-cartilage endplate (84).”
BackgroundSilwal, P., Nguyen-Thai, A. M., Mohammad, H. A., Wang, Y., Robbins, P. D., Lee, J. Y., & Vo, N. V. (2023) · Biomolecules · doi:10.3390/biom13040686 · Cited by 210
Autophagy in aging and longevity
Wong, S. Q., Kumar, A. V., Mills, J., & Lapierre, L. R. (2020) · Human Genetics · doi:10.1007/s00439-019-02031-7 · Cited by 201 · cited 1×
“Autophagy has been shown to prevent premature aging under various conditions, and autophagy defects may lead to aging (101, 102).”
BackgroundMetabolic messengers: glucagon-like peptide 1
Gribble, F. M., & Reimann, F. (2021) · Nature Metabolism · doi:10.1038/s42255-020-00327-x · Cited by 199 · cited 1×
“Glucagon-like peptide-1 (GLP-1) is a key intestinal insulin-stimulating hormone that regulates glucose and energy homeostasis (108, 109).”
BackgroundSingh, K., Masuda, K., Thonar, E. J.-M. A., An, H. S., & Cs-Szabo, G. (2009) · Spine · doi:10.1097/brs.0b013e31818e5ddd · Cited by 198
Low Back Pain: The Potential Contribution of Supraspinal Motor Control and Proprioception
Meier, M. L., Vrana, A., & Schweinhardt, P. (2019) · The Neuroscientist · doi:10.1177/1073858418809074 · Cited by 185
Wu, J., Chen, Y., Liao, Z., Liu, H., Zhang, S., Zhong, D., Qiu, X., Chen, T., Su, D., Ke, X., et al. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.05.021 · Cited by 185
Lee, J., Yun, J., & Ko, S. (2022) · Nutrients · doi:10.3390/nu14153086 · Cited by 181 · cited 1×
“The continuous increase of blood glucose levels in patients with diabetes can lead to non-enzymatic macromolecular glycosylation and eventually to the formation of advanced glycation end products (AGEs) (67, 68).”
BackgroundChou, R. (2021) · Annals of Internal Medicine · doi:10.7326/aitc202108170 · Cited by 179 · cited 1×
“Approximately 60-80% of patients experience chronic low back pain throughout their lifetime (3 – 5).”
BackgroundThe Nrf2 antioxidant defense system in intervertebral disc degeneration: Molecular insights
Xiang, Q., Zhao, Y., Lin, J., Jiang, S., & Li, W. (2022) · Experimental & Molecular Medicine · doi:10.1038/s12276-022-00829-6 · Cited by 178
Chen, B., Guo, J., Zhang, H., Zhang, Y., Zhu, Y., Zhang, J., Hu, H., Zheng, Y.-L., & Wang, X. (2017) · Clinical Rehabilitation · doi:10.1177/0269215517719952 · Cited by 177
Stem Cells and Exosomes: New Therapies for Intervertebral Disc Degeneration
Krut, Z., Pelled, G., Gazit, D., & Gazit, Z. (2021) · Cells · doi:10.3390/cells10092241 · Cited by 175 · cited 9×
“The main function of the CEP is to distribute the mechanical load along the spine to protect the vertebrae from compressive vertebral atrophy under pressure and to provide nutrition for the IVD (81).”
BackgroundInfluentialEpigenetic modifications of inflammation in intervertebral disc degeneration
Kang, L., Zhang, H., Jia, C.-Y., Zhang, R., & Shen, C. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101902 · Cited by 175
Jiang, L., Zhang, X., Zheng, X., Ru, A., Ni, X., Wu, Y., Tian, N., Huang, Y., Xue, E., Wang, X., et al. (2013) · Journal of Orthopaedic Research · doi:10.1002/jor.22289 · Cited by 171 · cited 1×
“In addition, the activation of the autophagy pathway in NP cells inhibits the expression of MMP-13 in diabetic IDD and triggers the protective mechanism of the NP cells (93, 94).”
BackgroundSelf-citationSilagi, E. S., Shapiro, I. M., & Risbud, M. V. (2018) · Matrix Biology · doi:10.1016/j.matbio.2018.02.025 · Cited by 171
Isa, I. L. M., Mokhtar, S. A., Abbah, S. A., Fauzi, M. B., Devitt, A. T., & Pandit, A. S. (2022) · Advanced Healthcare Materials · doi:10.1002/adhm.202102530 · Cited by 168
Lindbäck, Y., Tropp, H., Enthoven, P., Abbott, A., & Öberg, B. (2018) · The Spine Journal · doi:10.1016/j.spinee.2017.12.009 · Cited by 166
TGF-β signaling in intervertebral disc health and disease
Chen, S., Liu, S., Ma, K., Zhao, L., Lin, H., & Shao, Z. (2019) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2019.05.005 · Cited by 163
Mechanisms and clinical implications of intervertebral disc calcification
Zehra, U., Tryfonidou, M., Iatridis, J. C., Illien-Jünger, S., Mwale, F., & Samartzis, D. (2022) · Nature Reviews Rheumatology · doi:10.1038/s41584-022-00783-7 · Cited by 159
Liu, W., Ma, Z., Wang, Y., & Yang, J. (2022) · Bioactive Materials · doi:10.1016/j.bioactmat.2022.11.006 · Cited by 145 · cited 1×
“The CEP is composed of chondrocytes and matrix, located at the upper and lower edges of the vertebral body, and proteoglycan and type II collagen (80).”
BackgroundGianola, S., Bargeri, S., Del Castillo, G., Corbetta, D., Turolla, A., Andreano, A., Moja, L., & Castellini, G. (2022) · British Journal of Sports Medicine · doi:10.1136/bjsports-2020-103596 · Cited by 144
Liao, Z., Li, S., Lu, S., Liu, H., Li, G., Ma, L., Luo, R., Ke, W., Wang, B., Xiang, Q., et al. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.120850 · Cited by 144
Self-citationZhang, H., Liao, H.-Y., Bai, D.-Y., Wang, Z., & Xie, X. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112170 · Cited by 140 · cited 1×
“Age, repeated mechanical stress, occupational factors, metabolic disorders (such as obesity and diabetes), trauma, heredity, and even smoking may lead to the development of IDD (22 – 25).”
BackgroundSong, Y., Wang, Y., Zhang, Y., Geng, W., Liu, W., Gao, Y., Li, S., Wang, K., Wu, X., Kang, L., et al. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13067 · Cited by 139
Self-citationMechanobiology of annulus fibrosus and nucleus pulposus cells in intervertebral discs
Molladavoodi, S., McMorran, J. G., & Gregory, D. E. (2019) · Cell and Tissue Research · doi:10.1007/s00441-019-03136-1 · Cited by 134 · cited 2×
“The NP is located between the CEP and the AF, and is an elastic translucent gelatinous material composed of a crisscross fi brous reticular structure (84 – 86).”
BackgroundAstragaloside IV inhibits astrocyte senescence: implication in Parkinson’s disease
Xia, M.-L., Xie, X.-H., Ding, J.-H., Du, R.-H., & Hu, G. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01791-8 · Cited by 134
The Role of Oxidative Stress in Intervertebral Disc Degeneration
Cao, G., Yang, S., Cao, J., Tan, Z., Wu, L., Dong, F., Ding, W., & Zhang, F. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/2166817 · Cited by 134
Song, C., Zhou, Y., Cheng, K., Liu, F., Cai, W., Zhou, D., Chen, R., Shi, H., Fu, Z., Chen, J., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114711 · Cited by 132 · cited 1×
“Therefore, the incidence of IVD herniation in the elderly is signi fi cantly higher than that in young adults (89, 90).”
BackgroundApplication of mesenchymal stem cell therapy for aging frailty: from mechanisms to therapeutics
Zhu, Y., Ge, J., Huang, C., Liu, H., & Jiang, H. (2021) · Theranostics · doi:10.7150/thno.46436 · Cited by 132 · cited 1×
“In recent years, stem cell therapy has been widely used in cell-based regenerative medicine (97 – 99).”
BackgroundThe role of nerve fibers and their neurotransmitters in regulating intervertebral disc degeneration
Sun, K., Jiang, J., Wang, Y., Sun, X., Zhu, J., Xu, X., Sun, J., & Shi, J. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101733 · Cited by 127
DiStefano, T. J., Vaso, K., Danias, G., Chionuma, H. N., Weiser, J. R., & Iatridis, J. C. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202100596 · Cited by 120
Annulus fibrosus cell phenotypes in homeostasis and injury: implications for regenerative strategies
Torre, O. M., Mroz, V., Bartelstein, M. K., Huang, A. H., & Iatridis, J. C. (2018) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13964 · Cited by 112 · cited 1×
“The AF is a layered structure mainly composed of type I collagen (13, 14), whereas the CEP is composed of transparent cartilage located between IVD soft tissue and the vertebral bone structures (15, 16).”
BackgroundZhang, B., Xu, H., Wang, J., Liu, B., & Sun, G. (2017) · BioScience Trends · doi:10.5582/bst.2017.01199 · Cited by 110
Gene therapy and type 1 diabetes mellitus
Chellappan, D. K., Sivam, N. S., Teoh, K. X., Leong, W. P., Fui, T. Z., Chooi, K., Khoo, N., Yi, F. J., Chellian, J., Cheng, L. L., et al. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.09.138 · Cited by 108
Fields, A. J., Berg‐Johansen, B., Metz, L. N., Miller, S., La, B., Liebenberg, E. C., Coughlin, D. G., Graham, J. L., Stanhope, K. L., Havel, P. J., et al. (2015) · Journal of Orthopaedic Research · doi:10.1002/jor.22807 · Cited by 104
Astragaloside IV: A promising natural neuroprotective agent for neurological disorders
Yao, M., Zhang, L., & Wang, L. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114229 · Cited by 97
Cell therapy for the degenerating intervertebral disc
Tong, W., Lu, Z., Qin, L., Mauck, R. L., Smith, H. E., Smith, L. J., Malhotra, N. R., Heyworth, M. F., Caldera, F. E., Enomoto‐Iwamoto, M., et al. (2016) · Translational research · doi:10.1016/j.trsl.2016.11.008 · Cited by 89 · cited 1×
“Cell transplantation can secrete various cytokines, immune receptors, and anti-in fl ammatory molecules to regulate the microenvironment of host tissues (42, 43).”
BackgroundZhang, Y., Yang, B., Wang, J., Cheng, F., Shi, K., Ying, L., Wang, C., Xia, K., Huang, X., Gong, Z., et al. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/9503562 · Cited by 82
Yang, B., & O’Connell, G. D. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.09.035 · Cited by 79
Cell sources proposed for nucleus pulposus regeneration
Williams, R. J., Tryfonidou, M. A., Snuggs, J., & Maitre, C. L. L. (2021) · JOR Spine · doi:10.1002/jsp2.1175 · Cited by 78 · cited 1×
“Therefore, physiological osmotic pressure can easily dissipate any mechanical force transmitted through the spine (11, 12).”
BackgroundKlotho Deficiency Accelerates Stem Cells Aging by Impairing Telomerase Activity
Ullah, M., & Sun, Z. (2019) · The Journals of Gerontology: Series A · doi:10.1093/gerona/gly261 · Cited by 77 · cited 1×
“Cycloastragenol is the only telomerase activator that has anti-aging effects by increasing telomerase levels to delay telomere shortening (116, 117).”
BackgroundIllien-Jünger, S., Lu, Y., Qureshi, S. A., Hecht, A. C., Cai, W., Vlassara, H., Striker, G. E., & Iatridis, J. C. (2015) · PLOS ONE · doi:10.1371/journal.pone.0116625 · Cited by 74 · cited 1×
“This accelerates aging of the spinal structures (77).”
BackgroundPark, J.-S., Park, J., Park, I.-J., & Park, E. (2014) · International Orthopaedics · doi:10.1007/s00264-014-2296-z · Cited by 74 · cited 1×
“Studies have shown that AF cells of young rats treated with high glucose for 1 and 3 days showed increased mitochondrial damage and increased cell senescence markers, excessive production of ROS and decreased average telomerase activity (104).”
BackgroundTargeting Ferroptosis Holds Potential for Intervertebral Disc Degeneration Therapy
Chen, J., Yang, X., Feng, Y., Li, Q., Ma, J., Wang, L., & Quan, Z. (2022) · Cells · doi:10.3390/cells11213508 · Cited by 73 · cited 1×
“The main function of the CEP is to distribute the mechanical load along the spine to protect the vertebrae from compressive vertebral atrophy under pressure and to provide nutrition for the IVD (81).”
BackgroundWang, J., Hu, J., Chen, X., Huang, C., Lin, J., Shao, Z., Gu, M., Wu, Y., Tian, N., Gao, W., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201900703r · Cited by 69
Self-citationThe nucleus pulposus microenvironment in the intervertebral disc: the fountain of youth?
Guerrero, J., Häckel, S., Croft, A., Hoppe, S., Albers, C. E., & Gantenbein, B. (2021) · European Cells and Materials · doi:10.22203/ecm.v041a46 · Cited by 68
Notochord to Nucleus Pulposus Transition
Lawson, L. Y., & Harfe, B. D. (2015) · Current Osteoporosis Reports · doi:10.1007/s11914-015-0284-x · Cited by 66
Qi, L., Wang, R., Shi, Q., Yuan, M., Jin, M., & Li, D. (2018) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-018-0953-9 · Cited by 65
Advanced glycation end products in degenerative nucleus pulposus with diabetes
Tsai, T., Ho, N. Y., Lin, Y., Lai, P., Fu, T., Niu, C., Chen, L., Chen, W., & Pang, J. S. (2013) · Journal of Orthopaedic Research® · doi:10.1002/jor.22508 · Cited by 64
Jiang, Z., Lü, W., Zeng, Q., Li, D., Ding, L., & Wu, J. (2018) · Journal of Orthopaedic Research® · doi:10.1002/jor.24016 · Cited by 64
Yin, Y., Qu, H., Yang, Q., Fang, Z., & Gao, R. (2021) · Phytomedicine · doi:10.1016/j.phymed.2021.153749 · Cited by 61 · cited 1×
“Astragaloside IV (AG-IV) has a variety of drug properties, such as anti-in fl ammatory, anti-IR and neuroprotective effects (118 – 120).”
BackgroundLiang, W., Han, B., Hai, Y., Sun, D., & Yin, P. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.833840 · Cited by 59 · cited 1×
“Age, repeated mechanical stress, occupational factors, metabolic disorders (such as obesity and diabetes), trauma, heredity, and even smoking may lead to the development of IDD (22 – 25).”
BackgroundCurrent Treatment Options for Intervertebral Disc Pathologies
Eisenstein, S. M., Balain, B., & Roberts, S. (2020) · Cartilage · doi:10.1177/1947603520907665 · Cited by 57 · cited 1×
“Surgery can effectively relieve the symptoms of nerve compression and prevent the subsequent deterioration of muscle strength (33).”
BackgroundDong, L., Li, Y., Chen, Q., Liu, Y., Wu, Z., Pan, D., Yan, N., & Liu, L. (2023) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2023.2213768 · Cited by 57 · cited 1×
“AGEs are mainly accumulated in proteins, including aggregating glycans and collagen (69, 70), causing the fi bers to soften, rendering the dehydrated matrix unable to withstand the typical mechanical forces of the spine, resulting in biomechanical changes (71).”
BackgroundEmerging tissue engineering strategies for annulus fibrosus therapy
Zhang, A., Cheng, Z., Chen, Y., Shi, P., Gan, W., & Zhang, Y. (2023) · Acta Biomaterialia · doi:10.1016/j.actbio.2023.06.012 · Cited by 57
Hong, H., Xiao, J., Guo, Q., Du, J., Jiang, Z., Lu, S., Zhang, H., Zhang, X., & Wang, X. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10761 · Cited by 51
Self-citationThe Sirt1/P53 Axis in Diabetic Intervertebral Disc Degeneration Pathogenesis and Therapeutics
Zhang, Z., Lin, J., Nisar, M., Chen, T., Xu, T., Zheng, G., Wang, C., Jin, H., Chen, J., Gao, W., et al. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/7959573 · Cited by 48
Self-citationLumbar Arthroplasty: Past, Present, and Future
Sandhu, F. A., Dowlati, E. P., & Garica, R. (2019) · Neurosurgery · doi:10.1093/neuros/nyz439 · Cited by 48 · cited 1×
“Surgical treatment includes discectomy, fusion, and total disc replacement, and can be considered as the gold standard of IDD treatment (31, 32).”
BackgroundElectrospinning and 3D bioprinting for intervertebral disc tissue engineering
Pieri, A. D., Byerley, A. M., Musumeci, C. R., Salemizadehparizi, F., Vanderhorst, M. A., & Wuertz‐Kozak, K. (2020) · JOR Spine · doi:10.1002/jsp2.1117 · Cited by 48 · cited 1×
“With the development of three-dimensional (3D) printing technology and synthetic biomaterials, using arti fi cial intervertebral discs to replace degenerative IVD has gradually become feasible (34 – 36).”
The Role of Type I Diabetes in Intervertebral Disc Degeneration
Russo, F., Ambrosio, L., Ngo, K., Vadalà, G., Denaro, V., Fan, Y., Sowa, G., Kang, J. D., & Vo, N. (2019) · Spine · doi:10.1097/brs.0000000000003054 · Cited by 47
Shao, Z., Ni, L., Hu, S., Xu, T., Meftah, Z., Yu, Z., Tian, N., Wu, Y., Sun, L., Wu, A., et al. (2020) · Cell Proliferation · doi:10.1111/cpr.12975 · Cited by 47
Self-citationYao, M., Zhang, J., Zhi-hong, L., Bai, X., Ma, J., & Li, Y. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.630962 · Cited by 47
Krishnamoorthy, D., Hoy, R. C., Natelson, D. M., Torre, O. M., Laudier, D. M., Iatridis, J. C., & Illien‐Jünger, S. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.036012 · Cited by 44
Liu, Y., Li, Y., Nan, L., Wang, F., Zhou, S., Wang, J., Feng, X., & Zhang, L. (2020) · Cell Biochemistry and Function · doi:10.1002/cbf.3441 · Cited by 44 · cited 3×
“A high glucose concentration signi fi cantly decreases the proliferation, colony formation, migration, wound healing and dry maintenance of NP mesenchymal stem cells (NPMSCs) and accelerate the apoptosis and senescence of NPMSCs (96).”
BackgroundInfluentialBone mineral density and intervertebral disc height in type 2 diabetes
Agius, R., Galea, R. P., & Fava, S. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.01.021 · Cited by 42
Li, M., Wu, Y., Li, H., Tan, C., Ma, S., Jin, G., Dong, L., Huang, W., Li, X., & Deng, H. (2022) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2022.120193 · Cited by 42
Yao, M., Zhang, J., Li, Z., Guo, S., Zhou, X., & Zhang, W. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2019.106126 · Cited by 40 · cited 1×
“Therefore, Marein is a promising therapeutic agent to delay IDD in patients with diabetes (115).”
BackgroundLiu, Z., Wang, H., Yuan, Z., Wei, Q., Han, F., Chen, S., Xu, H., Li, J., Wang, J., Li, Z., et al. (2023) · Biofabrication · doi:10.1088/1758-5090/aca71f · Cited by 40
Hu, Y., Shao, Z., Cai, X., Liu, Y., Shen, M., Yao, Y., Yuan, T., Wang, W., Ding, F., & Xiong, L. (2018) · Spine · doi:10.1097/brs.0000000000002930 · Cited by 39 · cited 1×
“In AF cells, AGEs affects cell viability and proliferation by regulating mitochondrial apoptosis and ROS production in a dose-dependent manner (78).”
BackgroundIntervertebral disc degeneration in mice with type II diabetes induced by leptin receptor deficiency
Li, X., Liu, X., Wang, Y., Cao, F., Chen, Z., Hu, Z., Yu, B., Feng, H., Ba, Z., Liu, T., et al. (2020) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-020-3091-1 · Cited by 39 · cited 1×
“Furthermore, knockdown of the leptin receptor can increase the level of MMP3 and induce apoptosis (65).”
BackgroundSelf-citationThe Role of Advanced Glycation End Products on Dyslipidemia
Vekić, J., Vujčić, S., Bufan, B., Bojanin, D., Al-Hashmi, K., Al‐Rasadi, K., Stoian, A. P., Zeljković, A., & Rizzo, M. (2023) · Metabolites · doi:10.3390/metabo13010077 · Cited by 33 · cited 1×
“Long-term hyperglycemia can lead to decreased organ function due to various health complications (59, 60).”
BackgroundJung, M., Rospleszcz, S., Löffler, M. T., Walter, S. S., Maurer, E., Jungmann, P. M., Peters, A., Nattenmüller, J., Schlett, C. L., Bamberg, F., et al. (2022) · European Radiology · doi:10.1007/s00330-022-09140-4 · Cited by 31
Jiang, Z., Zeng, Q., Li, D., Ding, L., Lü, W., Bian, M., & Wu, J. (2020) · Molecular Medicine Reports · doi:10.3892/mmr.2020.11009 · Cited by 30 · cited 1×
“This suggests that MALAT1 can be used as a therapeutic target for diabetes related IDD (83).”
BackgroundTseng, C., Han, Y., Lv, Z., Song, Q., Wang, K., Shen, H., & Chen, Z. (2022) · Bone · doi:10.1016/j.bone.2022.116617 · Cited by 30
Yao, M., Jing, Z., Shu-qin, G., Xiao-liang, B., Zhi-hong, L., & Zhou, X. (2019) · Bioscience Reports · doi:10.1042/bsr20190109 · Cited by 29
Lu, R., Xu, H., Deng, X., Wang, Y.-G., He, Z., Xu, S., Liang, S., Huang, X., You, H., Guo, F., et al. (2023) · Journal of Orthopaedic Translation · doi:10.1016/j.jot.2023.01.001 · Cited by 29
The role of cycloastragenol at the intersection of NRF2/ARE, telomerase, and proteasome activity
Yılmaz, S., Bedіr, E., & Ballar, P. (2022) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2022.06.230 · Cited by 28
Natelson, D. M., Lai, A., Krishnamoorthy, D., Hoy, R. C., Iatridis, J. C., & Illien‐Jünger, S. (2020) · PLoS ONE · doi:10.1371/journal.pone.0227527 · Cited by 27
Yousef, C. C., Thomas, A., Matar, M. A., Ghandoura, L., Aldossary, I., Almuhanna, S. M., Alhussain, F. H., Bisher, F. B. A., Aljohani, R. M., Balubaid, A. N., et al. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.108871 · Cited by 27
Yu, X., Wang, Y.-G., Lu, R., Guo, X.-Z., Qu, Y., Wang, S., Xu, H., Kang, H., You, H., & Xu, Y. (2023) · Molecular Medicine · doi:10.1186/s10020-023-00623-8 · Cited by 23
Lintz, M., Walk, R. E., Tang, S. Y., & Bonassar, L. J. (2022) · JOR Spine · doi:10.1002/jsp2.1191 · Cited by 20
Mordechai, H. S., Aharonov, A., Sharon, S. E., Bonshtein, I., Simon, C., Sivan, S. S., & Sharabi, M. (2023) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.37519 · Cited by 17
Krishnamoorthy, D., Hoy, R. C., Natelson, D. M., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/342691 · Cited by 16
Glaeser, J. D., Ju, D. G., Tawackoli, W., Yang, J. H., Salehi, K., Stefanovic, T., Kanim, L. E. A., Avalos, P., Kaneda, G., Stephan, S. R., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249709 · Cited by 16 · cited 1×
“PM also promoted the increase in the level of oligosaccharides in rats (75).”
BackgroundXu, Y., Gu, Y., Yang, J., Xi, K., Tang, J., Bian, J., Cai, F., & Chen, L. (2021) · Cell Biology International · doi:10.1002/cbin.11574 · Cited by 16 · cited 1×
“The NP samples of clinical IDD patients were detected, and it was found that compared with non-diabetic IDD patients, the level of AGEs in diabetic patients was signi fi cantly higher than that in non-diabetic controls (72).”
ResultTseng, C., Chen, B., Han, Y., Wang, K., Song, Q., Shen, H., & Chen, Z. (2023) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2023.09.005 · Cited by 16
Liao, Z., Su, D., Liu, H., Xu, C., Wu, J., Chen, Y., Guo, W., Zhang, S., Li, Z., Ke, X., et al. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/8672969 · Cited by 13 · cited 1×
“On the drug therapy aspect, opioids, steroids, and non-steroidal anti-in fl ammatory drugs play an important role in controlling pain and improving function and quality of life (28 – 30).”
BackgroundChen, R., Liang, X., Huang, T., Zhong, W., & Luo, X. (2020) · Journal of Orthopaedic Surgery and Research · doi:10.1186/s13018-020-01784-6 · Cited by 10
Mahmoud, M., Kokozidou, M., Gögele, C., Werner, C., Auffarth, A., Kohl, B., Mrosewski, I., & Schulze-Tanzil, G. G. (2023) · Nutrients · doi:10.3390/nu15132872 · Cited by 10 · cited 1×
“In IDD induced by T2D, vitamin K2 diets may exert an anti-in fl ammatory function by regulating Socs3 and Hmox1 (66).”
BackgroundGallate, Z. S., D'Erminio, D. N., Nasser, P. R., Laudier, D. M., & Iatridis, J. C. (2023) · JOR Spine · doi:10.1002/jsp2.1254 · Cited by 9
Novel Intervertebral Technologies
Bydon, M., Goyal, A., & Yolcu, Y. U. (2019) · Neurosurgery Clinics of North America · doi:10.1016/j.nec.2019.08.006 · Cited by 3
Cited by
Glucagon-like peptide-1 receptor: mechanisms and advances in therapy
Zheng, Z., Zong, Y., Ma, Y., Tian, Y., Pang, Y., Zhang, C., & Gao, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01931-z · Cited by 1,036
Simone, M. D., Choucha, A., Ciaglia, E., Conti, V., Pecoraro, G., Santurro, A., Puca, A. A., Cascella, M., & İaconetta, G. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13195915 · Cited by 68
“A growing body of evidence has shown that pyroptosis mediated by the NLRP3 inflammasome plays a significant role in IVDD [37,38].”
BackgroundKong, C.-G., & Park, J. (2025) · Diagnostics · doi:10.3390/diagnostics15121510 · Cited by 14
“Immunohistochemical analysis in human IVDD samples has demonstrated increased levels of these cytokines and their receptors [3,11,13,29,30].”
InfluentialGradišnik, L., Kocivnik, N., Maver, U., & Velnar, T. (2025) · Bioengineering · doi:10.3390/bioengineering13010040 · Cited by 17
“Similarly, a sedentary lifestyle and poor posture reduce spinal flexibility and diminish the beneficial mechanical stimuli necessary for maintaining healthy IVD metabolism [32,33,65,66].”
InfluentialWu, Z., Chen, J., Luo, W., & Kuang, T. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1605764 · Cited by 13
Metadata
- Authors
- Li, S., Du, J., Huang, Y., Gao, S., Zhao, Z., Chang, Z., Zhang, X., & He, B.
- Affiliations
- Xi'an Honghui Hospital (CN)
- Corresponding author
- He, BaoRong
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2024-02-20
- Volume
- 15
- Pages
- 1355503-1355503
- ISSN
- 1664-3224 (ISSN-L)
- PMC
- PMC10912372
- OpenAlex
- W4391969990
- Cited by
- 32
- References
- 124
- Citations by year
- 2026: 18 · 2025: 11 · 2024: 3
- FWCI
- 2.39
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Immunology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Spine and Intervertebral Disc Pathology
- Health Sciences › Medicine › Rheumatology › Osteoarthritis Treatment and Mechanisms
- Health Sciences › Medicine › Surgery › Cervical and Thoracic Myelopathy
- Keywords
- intervertebral disc degeneration, hyperglycemia, diabetes mellitus, lumbar disc herniation, advanced glycation end products, extracellular matrix degradation, nucleus pulposus, annulus fibrosus, high-fat diet, glucose metabolism, inflammation, cellular senescence, apoptosis, pyroptosis, low back pain
- MeSH terms
- Nucleus Pulposus, Diabetes Mellitus, Glucose, Humans, Hyperglycemia, Intervertebral Disc Displacement, Intervertebral Disc Degeneration
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

